Trump joined by Joe Rogan as he signs order to speed up psychedelic review

Former President Trump, with podcaster Joe Rogan at his side, signs executive order to accelerate federal review of psychedelic substances for therapeutic use.

Former President Trump, with podcaster Joe Rogan at his side, signs executive order to accelerate federal review of psychedelic substances for therapeutic use. | Contesto: cronaca

Punti chiave

  • Trump joined by Joe Rogan as he signs order to speed up psychedelic review

Contesto

Former President Donald Trump, flanked by influential podcaster Joe Rogan, signed an executive order on Tuesday directing federal agencies to expedite the review and relax restrictions on psychedelic substances, including the African plant-derived compound ibogaine. The order, signed at a private club in Palm Beach, Florida, explicitly calls for the exploration of these substances as potential treatments for a range of mental health conditions, marking a significant shift in federal drug policy and aligning the executive branch with a growing bipartisan movement. The directive mandates the Department of Health and Human Services and the Food and Drug Administration to streamline research pathways and reconsider the current Schedule I classifications for substances like psilocybin, MDMA, and ibogaine. Schedule I status, reserved for drugs deemed to have no currently accepted medical use and a high potential for abuse, has long been cited by scientists as the primary barrier to rigorous clinical research. "The current framework has stifled science and denied hope," a senior administration official stated on background. "This order is about cutting through the bureaucracy to let the data lead." The presence of Joe Rogan, whose podcast regularly features discussions on psychedelics with scientists, advocates, and celebrities, underscores the cultural momentum behind the policy. Rogan, who did not speak at the signing ceremony but stood prominently behind the former president, has been an outspoken proponent of psychedelic therapy for conditions like depression, PTSD, and addiction. His audience of millions represents a key demographic, and his visible endorsement signals an effort to frame the issue beyond traditional political boundaries, appealing to a broad coalition of veterans' groups, mental health advocates, and libertarians. The order places particular emphasis on ibogaine, a powerful psychoactive substance with a controversial history. Derived from the root bark of the iboga plant, it has been used in West African spiritual ceremonies and, anecdotally, has shown remarkable promise in treating severe opioid addiction in clinics outside the United States....

Lettura DEO

Decisione di validazione: publish

Risk score: 0.1

Il testo è stato ricostruito dai dati editoriali disponibili senza aggiungere fatti non presenti nel record sorgente.

Indicatore di affidabilità

Verificata — Alta confidenza. Fonti affidabili confermano la notizia.

Il sistema a semaforo

Ogni articolo su DEO include un indicatore di affidabilità:

  • 🟢 Verificata — Alta confidenza. Fonti affidabili confermano la notizia.
  • 🟡 In evoluzione — Confidenza moderata. Alcuni dettagli potrebbero ancora cambiare.
  • 🔴 Contestata — Bassa confidenza. Fonti in conflitto o incertezze rilevanti.

Questo sistema esiste perché chi legge merita di sapere non solo cosa è successo, ma anche quanto la notizia è solida.


Categoria: cronaca